A 5-7 day ibogaine therapy program is offered by the Iboga Therapy House to individuals who are chemically dependent on heroin, methadone, other opiates, cocaine, crack and alcohol, who can demonstrate preparedness for a positive change in lifestyle.

We also offer a 2-3 day ibogaine psychotherapy program for personal therapeutic or spiritual purposes. Scroll down for further information about the application process.

****************************************************

*IMPORTANT NOTE*: We are currently closed for the Summer. We will begin accepting applications again in the Fall of '08. Please check back for updates and feel free to contact us at that time. Thankyou.

****************************************************

Applicants for Ibogaine-assisted Detoxification Therapy:

* Must be at least 19 years of age

* Should have an existing relationship with or be willing to see an outpatient counsellor for aftercare referral

* Must undergo an independent general medical evaluation through a family doctor or physician and supply results from the following medical tests:

an Electrocardiogram (ECG),

a Cell Blood Count (CBC) w/ differential,

a Liver panel (ALT/AST)

* Provide contact information for at least one or preferably two significant others (therapist, counselor, spouse, parent, sibling, close friend etc...) who will be contacted during the application period and in case of an emergency.

* Provide a short autobiography and drug use history including previous attempts at detoxification and recovery

* Be willing to inform themselves of both the potential effects (positive and negative) and possible risks of ibogaine therapy

* Be willing to fill out some questionnaires before and after treatment.

* Be willing to write a short report of the experience

Fees:

The fee for the 5-7 day detoxification therapy program is approximately $4700 CDN. The cost is dependent upon individual needs. Please call us for a quote at: +1 (604) 886-5767 or +1 (604) 989-0973

The fee for the personal psychotherapy program is approximately $3300 CDN (also dependent upon individual needs).

Application Interview:

Applicants will be contacted for an in-person or phone interview. Applicant names and personal contact information are kept strictly confidential.

Preparation:

Participants in ibogaine therapy should be prepared for a change in their lives, have options or plans for their future and, perhaps most importantly, have a social support network that is healthy, caring and supportive.

We will request a brief statement stating what the applicant plans to do for aftercare as this is a most important aspect of the recovery process. Setting goals and making plans for recovery can be very helpful and may be further explored with the aid of one of our counselors on staff. We will assist in offering referrals and helping participants enter into available programs after ibogaine therapy. Information regarding previous detoxifications and participation in various programs or therapies with some information on the outcomes of these other options (ie: why they did or didn't work) may assist in regards to aftercare referrals.

Ibogaine therapy should be considered as a 'catalyst' or 'tool' that may be highly effective in the detoxification and recovery process and not necessarily as a "quick fix" or "cure" in and of itself. Candidates should be prepared to have an experience that may affect them deeply on psychological, emotional and spiritual levels. Support from the facilitators and staff will be offered throughout the entirety of the therapy. The role of our facilitators is to provide a safe atmosphere of receptivity, caring and trust.

Please see the Ibogaine Patient's Bill of Rights for an understanding of patient/subject rights and responsibilities.

Contraindicated Conditions:

* Asthma * Bleeding problems * Cancer * Cerebellar dysfunction (Meneire’s disease, balance problems etc…) * Chronic blood clots * Chronic fainting * Diabetes * Emphysema * Epilepsy * Gastrointestinal tract diseases (Crohn’s, IBD) * Gynecological problems * Heart attack * Heart failure * Heart murmur * Heart surgery * Heart irregularities * HIV/AIDS * Kidney problems * Palsy * Pregnancy * Psychiatric problems * Seizures * Stroke * Thyroid problems * Tremors * Tuberculosis * Ulcers.

Anyone who is taking antipsychotic medication or anyone on long-term medication that may cause possible negative interactions with ibogaine will be required to taper down from the medication with the assistance of their doctor before taking ibogaine (only in cases where it is deemed by the doctor to be safe to do so) or will not be accepted for ibogaine therapy. We urge strong caution in this regard and proper consultation with the prescribing doctor.

Possible Side Effects:

Potential side effects typically associated with drug interruption doses of Ibogaine include: ataxia (temporary loss of muscle coordination), tremors, photosensitivity (sensitivity to light), nausea and slight changes in blood pressure. Any side effects experienced subside 24-48 hours after the onset of therapy and are not considered withdrawal symptoms (which should be significantly removed through the action of the ibogaine). Some individuals may experience short-term back pain which can be resolved through stretching, baths, exercise and massage.

Pain Management:

For those with pain management issues, we will determine readiness for the program only if the applicant can demonstrate that options for dealing with pain have been examined in full detail and that steps have been taken to seek out professional help in this regard. It is strongly suggested that the applicant demonstrate that options for effectively dealing with pain have been seriously considered.

Consent:

We require that all applicants recommended for therapy first read, sign and date a consent form. This form serves to inform the applicant of possible effects, risks and procedures for the therapy as well as releasing the providers from liability.

Therapeutic Procedures:

Our therapy protocol is modeled on the Manual for Ibogaine Therapy: Screening, Safety, Monitoring & Aftercare,Second Revision by Howard S. Lotsof & Boaz Wachtel.

For more information please see our Ibogaine Therapy information page.